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Abstract
Here, we report on the design of braided peripheral nerve conduits with barrier coatings. Braiding of extruded polymer
fibers generates nerve conduits with excellent mechanical properties, high flexibility, and significant kink-resistance.
However, braiding also results in variable levels of porosity in the conduit wall, which can lead to the infiltration of
fibrous tissue into the interior of the conduit. This problem can be controlled by the application of secondary barrier
coatings. Using a critical size defect in a rat sciatic nerve model, the importance of controlling the porosity of the nerve
conduit walls was explored. Braided conduits without barrier coatings allowed cellular infiltration that limited nerve
recovery. Several types of secondary barrier coatings were tested in animal studies, including (1) electrospinning a layer
of polymer fibers onto the surface of the conduit and (2) coating the conduit with a cross-linked hyaluronic acid-based
hydrogel. Sixteen weeks after implantation, hyaluronic acid-coated conduits had higher axonal density, displayed higher
muscle weight, and better electrophysiological signal recovery than uncoated conduits or conduits having an electrospun
layer of polymer fibers. This study indicates that braiding is a promising method of fabrication to improve the mechanical
properties of peripheral nerve conduits and demonstrates the need to control the porosity of the conduit wall to
optimize functional nerve recovery.
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Introduction
Synthetic nerve conduits have been developed over the
past 50 years as an alternative to autologous nerve grafts
for repairing peripheral nerve lesions that cannot effectively be bridged using end-to-end neurorrhaphy. At least,
seven different synthetic nerve guidance conduits have
been approved for clinical application in the United States,
but autografts continue to be preferred for repairing nerve
gaps longer than 4 cm.1,2 Synthetic conduits have been
found to fail because of swelling and reduction of luminal
volume,3 suture pull-out,4,5 collapse,6 and lack of mechanical strength to withstand the traction of moving joints.7
Here, we report on our study of braided conduits, which
have significantly improved mechanical strength and a
very high degree of kink-resistance.
Braiding has been used to fabricate vascular stents,8,9
but there have only been a few reports on braided nerve

conduits,10–18 and none of the conduits in clinical use in the
United States are braided. Since braided vascular stents
were shown to possess excellent mechanical strength and
flexibility,19,20 we expected braiding to impart favorable
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mechanical properties to nerve conduits as well. Braided
conduits are fabricated by first generating small diameter
fibers that are either used individually or twisted together
to form multi-filament yarns. The fiber or yarn is loaded
into the carriers of a braiding apparatus, which travel in an
interlacing pattern around a center point and wrap the fibers around a mandrel to generate a tubular conduit.
Braiding may be performed using a variety of braiding
parameters, patterns and angles, which determine the
physical and mechanical characteristics of the final braid,
along with the mandrel diameter which determines the
tube’s inner diameter and the individual fiber or yarn
diameter which determines the thickness of the conduit
walls. Once suitable fibers are available, braided conduits
can be rapidly and reproducibly fabricated without dimensional limitations.
Our studies were conducted using a tyrosine-derived
polycarbonate to generate the fibers via melt extrusion.
The library of tyrosine-derived polycarbonates encompasses over 10,000 polymers with a wide range of properties and applications in tissue regeneration and drug
delivery.21–24 For the studies described here, we selected a
single polymer composition, poly(desaminotyrosyl-tyrosine ethyl ester carbonate). This polymer, referred to as
poly(DTE carbonate) and abbreviated as “E0000,” is a
derivative of naturally occurring tyrosine dipeptide, and
degrades very slowly in vivo releasing non-toxic diphenolic monomers and requiring over 1 year before significant changes in molecular weight are apparent.25,26
Conduits composed of E0000 will therefore experience
only negligible degradation within the time span of our
studies and effectively remove degradation as a variable in
conduit performance.
Three research groups have previously reported on the
testing of braided nerve conduits in vivo. Nakamura and
colleagues10–12,18,27,28 have developed conduits braided
from poly(glycolic acid) (PGA) fibers and coated with collagen (PGA-c-tube) since 1995. These conduits were used
to repair 10–80 mm long nerve defects in cats and dogs,
have been in clinical use in Japan since 2002, and were
successfully used to treat Complex Regional Pain
Syndrome Type II in two human patients.13 This group
later incorporated poly(l-lactic acid) fibers into the PGA
braid structure (PLLA/PGA-c-tube) to address the premature degradation and loss of mechanical properties of the
PGA-c-tube, and demonstrated improved outcomes in a
40 mm canine model.14 Ramakrishna and coworkers separately reported favorable in vitro cytocompatibility and
swelling behavior with conduits braided from poly(lacticco-glycolic acid) (PLGA) or chitosan fibers.15 These conduits showed 90% success in bridging a 12 mm gap in the
rat sciatic nerve after 1 month.16 Finally, Lu et al.17 evaluated peripheral nerve regeneration in the 10-mm rat sciatic
nerve model using poly(lactic acid) (PLA) fiber-reinforced
conduits. Using twisted PLA multi-filaments, they braided
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single, double, or triple-layered conduits to obtain smaller
pore size with each additional layer. An 8-week in-vivo
study did not show any differences in electrophysiology
and histology due to the different layers. While these
reports showed the promise of braided nerve conduits,
they did not address the relationship between conduit pore
size and resulting tissue infiltration or the longer-term outcomes of nerve regeneration with these conduits.
Studies of the effect of conduit pore size on the outcome of nerve regeneration have shown the optimal pore
size for conduits to be in the 5–30 µm range to enable
nutrient and waste diffusion and minimize fibrotic and
inflammatory cell infiltration.29–31 However, considerable variation in outcomes has been reported in studies
using conduits that differ in composition, method of fabrication, and the animal model used to test the conduits.
It is important to note that most studies in vivo are performed in mice or rats where the conduit length is usually
around 10 mm only. It is generally agreed that porosity
will play an increasingly important role if conduits are to
be used in bridging longer nerve gaps where diffusion
from the termini of the conduits will limit nutrient
exchange.
We found that variations in braiding lead to significant
changes in the porosity of the conduits, resulting in
macroporous structures. We also show that modulating
conduit porosity has a significant effect on in-vivo nerve
regeneration outcomes. Our work serves as an evaluation
of kink-resistant braided conduits and accompanying barrier coatings and demonstrates that braiding, in combination with the control of conduit wall porosity is a promising,
but largely overlooked approach for the development of
improved synthetic nerve conduits.

Materials and methods
Polymer synthesis and characterization
Poly(DTE carbonate), E0000, was synthesized and purified utilizing previously published procedures.26 Molecular
weights (number average, Mn; weight average, Mw,) and
polydispersity index (PDI) were determined using gel permeation chromatography (GPC; Waters Corporation,
Milford, MA) relative to polystyrene standards in dimethylformamide containing 0.1% trifluoroacetic acid as the
mobile phase. The glass transition temperatures (Tg) of the
polymers were determined as described before.32 E0000
used to fabricate braided conduits and dipcoated conduits
had a Mn of 167,700 Da with a PDI of 1.47 and Tg of
96.5°C. The electrospun coatings were fabricated using
E1001(1k), a copolymer consisting of 89 mol% DTE, 10
mole percent desaminotyrosyl-tyrosine (DT), and 1 mol%
1 kDa poly(ethylene glycol) (PEG). E1001(1k) was synthesized using previously published procedures33 and had
a Mn of 239,000 Da with a PDI of 1.6 and Tg of 97.0°C.
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Conduit fabrication
Different braid designs were initially implemented using
60 µm thick industrial polypropylene (PP) prototype yarn
(ATEX Technologies Inc, Pinebluff, NC) to determine the
effect of braid pattern and fiber density on the conduit pore
size and mechanical properties (not shown).
Braided conduits used for in-vitro and in-vivo tests were
fabricated by tubular braiding of E0000 fibers. E0000 was
melt extruded using a 3/8 inch single-screw extruder
(Microextruder; Randcastle, Cedar Grove, NJ) and extruded
fiber diameter was monitored using a laser micrometer
(Z-Mike 1200 series, Groß-Umstadt, Germany). The final
extruded fiber diameter ranged between 80 and 110 µm and
the post fabrication Mn was 138,550 Da with a PDI of 2.05.
Three polymer fibers were then twisted together to form a
multi-filament yarn and spooled onto braiding spindles. A
Herzog NG 1/24-120 tubular braiding machine (Herzog
Maschinenfabrik, Oldenburg, Germany) equipped with 24
carriers was used to braid conduits in a 2/2 braid pattern,
over a Teflon mandrel with an outer diameter of 1.5 mm
(Applied Plastics Co., Inc., Norwood, MA). After braiding,
conduits were cut to desired lengths and ends were trimmed
and sealed using a thermocutter (ZTS 20; AZ Zangl,
Germany). Conduits were cleaned by sequential washes in
cyclohexane (1×), 0.5 volume percent Tween20 in deionized water (1×), and distilled (DI) water (5×) while being
sonicated.
To control conduit porosity, secondary electrospun layers were formed on the braided conduits on rotating mandrels in an electrospinning setup using a high voltage
power supply (Gamma High Voltage Research Inc., Omaha
Beach, FL) and a syringe pump (KD Scientific, Holliston,
MA) connected to blunt tipped 23G stainless steel needles
via 20 gauge × 3′ Teflon tubing (both from Hamilton
Company, Reno, NV). Polymer (10% (w/v)) solution of
E1001(1k) was prepared in glacial acetic acid (Fisher
Scientific, Pittsburgh, PA) using a 1:25 ratio of trans-4-hydroxy-l-proline (tHyp):E1001(1k) to eliminate beading
from the electrospun fibers.34 Conduit external diameter
was periodically measured with calipers and electrospinning was continued until a 300 µm thick coating was
formed around the braided conduits. Conduits were thoroughly dried in the fume hood to remove residual solvent.
Alternatively or in combination with elecrospun polymer coating, sterile braided conduits were also dipcoated
in a 1% (w/v) sterile thiol-modified hyaluronan solution
(HyStem) followed by immediate cross-linking by dipcoating in a sterile 1% (w/v) poly(ethylene glycol diacrylate) (PEGDA) solution (both from Glycosan
Biosystems-BioTime, Inc. Alameda, CA) in a sonicated
water bath. Conduits were dried for 5 min after each dipcoating step and the process was repeated for a total of five
times. Conduits with dual electrospun and hyaluronic acid
(HA) coating were fabricated by first depositing the

electrospun layer on the braided conduits as described
above, followed by dipcoating in hyaluronan and PEGDA
solutions. HA-coated conduits were dried overnight in the
laminar flow hood and implanted in dry state for in-vivo
experiments.
Dipcoated conduits were fabricated as controls via dipcoating from a 20% (w/v) E0000 solution in methylene
chloride using previously published procedures,35 and
deposited on 1.5 mm OD teflon-coated mandrels.
To reduce the bioburden, all conduits were exposed to
UV irradiation for 40 min prior to in-vivo use.

Scanning electron microscopy
Pore size and topography of sputter-coated (SCD 004 sputter coater, 30 mA for 120 s with Au/Pd) specimens were
evaluated using scanning electron microscopy (SEM;
Amray 1830I, 20 kV). Pore size, braid angle and wall
thickness of conduits, and the fiber diameter of electrospun mats were measured on SEM images using ImageJ
(public domain software from National Institutes of
Health). Braid angle was measured between a line perpendicular to the longitudinal axis of the braid and a line parallel to the groups of fibers aligned close to the tube-axis.

Mechanical testing
Mechanical properties of braided conduits were characterized by compressive and three-point bending tests using a
Syntec 5/D mechanical tester, and tensile tests using a
MTS Tytron™ 250 Microforce Testing System (both from
MTS, Eden Prairie, MN). Samples were preconditioned by
incubation in phosphate-buffered saline (PBS) at 37°C
overnight and tested immediately after removal from the
incubator. Compression tests were performed on 1 cm long
conduits, with a transverse crosshead speed of 6 mm/min
to the endpoint displacement equivalent to 60% of initial
conduit diameter. The compressive stiffness was calculated from the slope of the linear region in the force versus
displacement curves. Three-point bending tests were performed on 1.5 cm long conduits placed on the lower holder
beams of the bending apparatus, which were set 1 cm apart.
The third point was lowered from above the midpoint of
the conduit at a crosshead speed of 10 mm/min. Bending
stiffness (EI) was calculated using the formula EI = (F/d)
(L^3/48), where F/d is the slope of the linear region in the
force versus displacement curves and L = 10 mm is the
beam separation. For tensile testing, 3 cm long conduits
were secured in the grips, with a grip separation of 2 cm
and stretched at a speed of 20 mm/min until failure. The
tensile stiffness was similarly calculated from the slope of
the linear region in the force versus displacement curves.
Kink tests were performed by bending 3 cm long conduits
on a flexible 0.6 mm diameter wire (Applied Plastics Co.,
Inc.) until a kink occurred, which was defined as visually
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detectable reduction in the conduit outer diameter at the
point of bending. E0000 conduits fabricated by braiding
and dipcoating as well as commercially available
NeuraGen® conduits (Integra LifeSciences Corporation,
Plainsboro, NJ) were bent and kink formation at the bending point was observed. The angle between the bent arm of
the conduits and the horizontal axis was measured and
reported as the bending angle. For braided conduits, kink
test was carried out further by bending the conduit in a
loop until a kink occurred. For this test, braided conduits
were gradually twisted into smaller loops and photographed at each increment. The perimeter of the inner loop
formed by the conduit was then measured using ImageJ
software and the corresponding internal loop diameter was
calculated from the perimeter, assuming a circular loop.

In-vivo evaluation
All experiments were conducted under an approved protocol of the Rutgers Animal Care and Facilities Committee
and the Institutional Animal Care and Use Committee
(IACUC).
Subcutaneous implantation of braided conduits. Male
Sprague-Dawley rats weighing 250–300 g (Charles River
Labs, Wilmington, MA) were anesthetized by intraperitoneal injection of ketamine/xylazine (75/10 mg/kg, respectively) and braided conduits were implanted in four
subcutaneous pockets on the animals’ backs. Animals were
sacrificed 3 weeks after implantation, and conduits were
explanted with the surrounding connective tissue. Immediately after explantation, conduits were fixed in 10% buffered formalin, followed by tissue processing and paraffin
embedding for histological staining. 6 µm sections were
prepared and stained with hematoxylin and eosin (H&E)
using standard methods.
In-situ implantation of conduits in the 1-cm rat sciatic nerve
model. Female Lewis rats weighing 200–250 g (Charles
River Labs) were anesthetized by intraperitoneal injection
of ketamine/xylazine (75/10 mg/kg, respectively) and
implanted with conduits, using published protocols.36,37
For the conduit groups, a 5 mm section of the sciatic nerve
was removed and the nerve stumps were allowed to retract
to form a 10 mm gap. Sterile conduits (1.2 cm long and
1.5 mm in diameter) were then sutured to the nerve stumps
using two 9-0 epineurial sutures on each end, maintaining
the 10-mm gap between the stumps. In the case of autografts, a 1 cm segment of nerve was removed, reversed,
and sutured back in the gap using three to four 9-0 sutures
on each end.
Electrophysiology. Recovery of the electrophysiological
function after nerve injury was evaluated under general
anesthesia by measuring the compound muscle action
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potentials (CMAPs) at the dorsal and plantar foot muscles,
which are the most distal targets of the peroneal and tibial
branches of the sciatic nerve.37 CMAPs were recorded
immediately before surgery (intact animals) and every
4 weeks after surgery using the VikingQuest EMG system
(Natus Medical Inc., San Carlos, CA). Subcutaneous electroencephalogram (EEG) needles were used as recording,
reference, and ground electrodes. Reference and ground
electrodes were placed at the lateral side 5th metatarsal
and heal calcaneus, respectively, on the operated side of
the rat. Recording electrode was inserted subcutaneously
on the dorsal foot muscle over the 3rd metatarsal for the
peroneal CMAP, and on the plantar muscle for the tibial
CMAP. The sciatic nerve was stimulated percutaneously
using a bipolar stimulating electrode at the ankle level
directly posterior to the tibia. Electrodes were adjusted
locally to produce maximal CMAP amplitude and the
stimulus was increased incrementally to produce a
supramaximal response. The average of three consecutive
CMAP amplitudes, measured from the onset of the CMAP
signal to the top of the peak, and three consecutive latencies were calculated for each animal and averaged for the
animals in the same treatment group for plotting.
Histomorphometric analysis of explanted nerves. Sixteen
weeks after surgery, rats were deeply anesthetized using
ketamine/xylazine anesthesia, the sciatic nerve on the operated side was exposed and in-situ fixation of the nerve was
performed by immersing the nerve in Trump’s fixative for
30 min. The nerve was then harvested and processed as
described previously.36 Total numbers of myelinated axons
per nerve cross-section were counted using ImageJ 1.43u
software, by counting a minimum 500 myelinated axons in
random 100× images for each 1 µm thick nerve section and
averaging over three replicate nerve sections. The raw tissue area, cross-sectional area of the myelinated nerve cable,
and the % nerve regeneration were measured on the 10×
images and analyzed with ImageJ 1.43u software. Axonal
(inside the myelin sheath) and nerve fiber (including the
myelin sheath) diameter were measured in three random
100× samples from each section to calculate the G-ratio.38
Muscle harvest. Upon nerve harvest, animals were euthanized by CO2 asphyxiation. The tibialis anterior (TA) and
gastrocnemius muscles of both hind limbs (healthy and
operated side) were immediately harvested by exposing
the musculature via a knee to ankle longitudinal skin incision. The muscles were harvested from origin to insertion
and weighed with an electronic balance.

Statistical methods
Data in this study are represented as mean ± SE unless otherwise indicated. One-way analysis of variance (ANOVA)
tests with Dunnett’s post hoc tests were used in this study
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Table 1. Comparison of physical properties of braided conduit variations.

Braid angle
Pore size (µm)

Single-fiber 2/2
PP braid

Three-fiber triaxial
PP braid

Three-fiber 2/2
PP braid

Three-fiber 2/2
E0000 braid

39.0 ± 0.9
59.3 ± 14

47.4 ± 3.4
15.2 ± 3.7

40.0 ± 1.0
45 ± 8.1

41.8 ± 0.4
65.0 ± 19.5

Figure 1. Kink tests were performed on the (a) dipcoated E0000, (b) NeuraGen®, and (c, d) braided conduits by bending the conduit
on a flexible 0.6 mm diameter wire until a kink in the lumen occurred. For the dipcoated conduits and NeuraGen®, a visible collapse
in lumen diameter occurred when the conduit was bent at 29.28° and 55.01°, respectively, from the horizontal axis. Braided conduits
resisted kinking, maintained constant lumen diameter when bent at large angles, and resumed their original shape when the load was
released, while dipcoated and Neurogen conduits partially or completely occluded the lumen when bent and did not resume their
original shape. Braided conduits displayed a reversible kink when bent into a loop with a corresponding radius of curvature of 1.29 mm.

to assess significant differences. Statistical significance
was defined as p < 0.05.

Results and discussion
Conduit fabrication and physical
characterization
There are many variables for braiding, which can have significant effects on the physical and mechanical features of
braided devices.8,39 We first explored three conduit prototypes by varying the number of filaments and twists in a
yarn using commercially available non-degradable PP prototyping fibers. The resulting conduits indeed showed substantial differences in physical characteristics, such as pore
size and braid angle (Table 1). The 2/2 braid constructed
from three-fiber yarn had the most favorable mechanical
features, demonstrating superior kink-resistance and elastic deformation. In contrast, triaxial braids were stiffer and
exhibited undesirable shape memory upon deformation.
Owing to a combination of pore size and mechanical properties, we explored the traditional 2/2 braiding method in
more detail using E0000 fibers with diameters of 80–
110 µm. The resulting conduits had an average pore size of
65 ± 19 µm and an inner lumen diameter of 1.5 mm.

Mechanical properties of braided conduits
Nerve conduits must not collapse6 and retain mechanical
stability to withstand the traction of moving joints.7 For the

repair of large nerve gaps in areas of high mobility, flexibility and prevention of kinking are important conduit
design criteria. We compared the mechanical properties of
braided E0000 conduits, non-porous dipcoated E0000
conduits with 183 ± 15 µm thick walls, and the clinically
used NeuraGen® conduits consisting of collagen I (Integra
Lifesciences, South Plainfield, NJ).40,41 Due to the inability to secure a sufficient quantity of the NeuraGen® conduits, not all experiments could be replicated with these
conduits and the previous findings of Yao et al.42 using
these conduits are cited to complete the comparison.
Kink tests were performed to assess the angle to which
the E0000 conduits can be bent before any luminal occlusion occurs. Conduits were bent on a wire until a kink
occurred (Figure 1). For the dipcoated conduits and
NeuraGen®, a visible decrease in lumen diameter occurred
when the conduits were bent 29.3° and 55.0°, respectively,
from the horizontal axis (Figure 1(a) and (b)). Braided
conduits resisted kinking, maintaining constant lumen
diameter when bent at angles exceeding 125° (Figure 1(c)
and (d)). Braided conduits also resumed their original
shape after release of the load, whereas dipcoated and
NeuraGen® conduits did not resume their original shape.
These results indicate that our braided conduits are
highly resistant to luminal occlusion and are much more
likely to maintain an open lumen when applied in areas of
high flexation. The large flex angles allowed by the braided
conduits are physiologically relevant; elbow, knee, and
finger joints routinely bend at high angles well in excess of
90°. Failure due to breakage near the knee joint has been
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Figure 2. Representative load (N) versus displacement (mm) curves for (a) compression, (b) three-point-bending, and (c) tension
and testing of E0000 braided conduits.
Table 2. Compressive structural stiffness, bending stiffness, tensile structural stiffness and ultimate tensile strength calculations for
the dipcoated E0000, NeuraGen® and braided E0000 conduits (mean ± SD of three samples tested).
Dipcoated
Compressive structural stiffness (N/mm)
Bending stiffness (EI, N mm2)
Tensile structural stiffness (N/mm)
Ultimate tensile strength (N)
Kink angle (°)
aData

34.6 ± 2.57
22.16 ± 0.54
166.71 ± 41.09
43.46 ± 10.61
29.28

NeuraGen®
0.92 ± 0.15 (Yao et al.)a
N/Aa
2.38 ± 0.86 (Yao et al.)a
6.89 ± 2.6 (Yao et al.)a
55.01

Braided
9.4 ± 0.58
5.69 ± 0.25
1.27 ± 0.03
34.7 ± 3.05
127.60

from Yao et al. are tabulated as comparison for the NeuraGen conduits due to limited supply of NeuraGen conduits for this study.

reported for 22 mm long collagen tubes that were used in
the rat sciatic nerve injury model due to insufficient flexibility of tubular constructs.43
Results of quantitative mechanical tests for the braided
conduits are shown in Figure 2 and compared to dipcoated
and NeuraGen® conduits in Table 2. In transverse compression, the dipcoated conduits displayed the most resistance to
the applied load but plastically deformed when compressed

to 60% of the inner diameter, while the braided conduits
regained their original shape immediately after removing the
compressive load. The reported data of the NeuraGen® conduits indicate that under compression, these conduits (compressive stiffness: 0.92 ± 0.15 N/mm) deform 10-fold more
than the braided conduits (compressive stiffness:
9.4 ± 0.58 N/mm).42 Similar trends were noted for three
point-bending experiments for dipcoated (bending stiffness
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Figure 3. Cross-sectional view of E0000 braided conduit after 3 weeks of subcutaneous implantation in rats. Hematoxylin and
eosin stained section where Λ marks the conduit, arrows mark the fibrous capsule, and asterisk mark the infiltrating tissue. (a) 2.5×
magnification showing the cross-section of the entire conduit and surrounding tissue, (b) 10× magnification showing the close-up
view of the braided conduit fibers (lower half of the image), the fibrous capsule, and surrounding tissue, and (c) 40× magnification
showing the thickness of the fibrous capsule.

22.16 ± 0.54 N/mm) and braided (bending stiffness
5.69 ± 0.25 N/mm) conduits, with dipcoated conduits showing greater resistance to bending. No bending data were
reported for NeuraGen® conduits. The fact that braided conduits can freely bend, without occluding their lumen, is a
critical advantage over the other conduits that are either too
stiff to bend, and thus may cause tissue damage, or result in
a kink at the bending point, crushing the newly formed nerve
cable. In terms of tensile stiffness, braided (tensile stiffness:
1.27 ± 0.03 N/mm) and NeuraGen® (tensile stiffness:
2.38 ± 0.86 N/mm) conduits were more compliant and
yielded more readily to tension than the dipcoated (tensile
stiffness: 166.71 ± 41.09 N/mm) conduits. The braided conduits deformed elastically under physiological loading conditions, which is beneficial for nerves that experience
movement and tensile stress. On the other hand, the ultimate
tensile strength (UTS) of the braided conduits (UTS:
34.7 ± 3.05 N/mm) was 5-fold higher than NeuraGen® (UTS:
6.89 ± 2.6 N/mm) demonstrating the strength of the braided
structure as compared to NeuraGen®. Peripheral nerves experience tensile, compressive, and shear forces created by the
limb movement and muscular contraction.44,45 Synthetic nerve
conduits need to tolerate these forces while protecting the
regenerating nerve from damage. Peripheral nerves are under
tensile loads in situ and experience ~11% strain in resting position46,47 while tolerating 11.7 MPa maximum tensile stress.48
Therefore, any nerve conduit that acts to bridge a peripheral
nerve gap should be able to reversibly elongate under loads up
to 11.7 MPa. We found this load is within the linear portion of
the stress–strain curve of the E0000 braided conduits, which
show 17%–22% reversible strain under this load, sufficient to
withstand the stress of limb movements (Figure 2(c)).

Host response
A small control study was conducted to ensure that the
conduit material does not elicit a strong inflammatory

response that could affect the results obtained in the subsequent nerve regeneration studies. To evaluate the gross
tissue response, E0000 braided conduits were implanted
into subcutaneous pockets on the backs of adult rats.
After 3 weeks, conduits were removed and H&E histology was performed. Sections revealed the expected formation of a fibrous capsule around the conduits (Figure
3). Capsule tissue was diffusely organized and lacked a
high concentration of inflammatory cells, indicating that
the host response to the E0000 braided conduit was minimal and in agreement with previous findings on the host
response to polymers within the family of tyrosinederived polycarbonates.33,49
A pilot 4-week study to evaluate the effectiveness and
tolerance of barrier coatings consisting of HA, alginate, or
agarose hydrogels on braided conduits was also performed.
Gross morphological and histological analysis on the
explanted conduit and the surrounding tissues showed no
signs of adverse tissue reaction when PEGDA cross-linked
HA hydrogels were used as a barrier coating on the braided
conduits (not shown).
Electrospun E1001(1k) mats, also used as secondary
barrier coatings on the braided conduits, were not expected
to invoke a host immune response, owing to the established use of this material in a number of tissue regeneration applications,21,23,35 and hence were not tested in this
study for inflammatory response.

Secondary coatings
The H&E stain in Figure 3 also revealed that surrounding
tissue penetrated through the pores and entered into the
E0000 conduit lumen. Effects of conduit pore size on the
outcome of nerve regeneration have been investigated and,
while results and interpretations of this critical aspect vary
widely, the optimal pore size for conduits was reported to
be in the 5–30 µm range to enable nutrient and waste

8

Journal of Tissue Engineering

Figure 4. SEM images of conduit surface from side view (top panel, scale bar 1 mm), cross-sectional (end) view showing conduit
wall thickness (middle panel, scale bar 100 µm), and a single pore area (bottom panel, scale bar 10 µm) and (a) uncoated braid
(Group 1), (b) HA-coated braid (Group 2), (c) electrospun (ES) mat-coated braid (Group 3), and (d) ES and HA-coated braid
(Group 4).

diffusion and minimize fibrotic and inflammatory cell
infiltration.30,31,50 E0000 braided conduits have pore
dimensions ranging from 20 to 140 µm with an average
pore size of 65 ± 19 µm and are therefore susceptible to tissue infiltration. To address this potential problem, we
developed temporary micro or nanoporous barrier coatings
that allow for nutrient exchange, but reduce the ability of
non-nerve cells to infiltrate into the conduit and disrupt
regeneration.
Three conduit coatings were explored (Figure 4): a
hydrogel coating consisting of cross-linked HA, a layer of
electrospun E1001(1k) applied on the surface of the conduit, and a combination of the electrospun layer subsequently coated with HA. We used a high molecular weight
and PEGDA cross-linked version of HA that we found to
repel the attachment of fibroblasts (data not shown). The
PEGDA cross-linked HA hydrogels are reported to be stable for 4–8 weeks in-vivo51 but to our knowledge have not
been used in this manner as a nerve conduit coating.
The secondary coating methods provided varying
degrees of coverage on the macropores of braided conduits. The thin HA coating was nanoporous, while the

electrospun layer was microporous, with an average thickness of 292 ± 39 µm, fiber diameter of 0.26 ± 0.06 µm, and
pore size of 2.02 µm. The pore size was calculated using
the equation derived by Sampson,52 assuming a pore fraction of 0.85. To apply a coating of HA on top of the electrospun fiber mats, the conduits were sonicated while
dipcoating them into a solution of HA. This treatment
facilitated the diffusion of the HA hydrogel through the
electrospun fiber mat and thoroughly coat around the fibers of the mat and the underlying conduit to create an
apparently non-porous barrier. The electrospun layer
shrank upon coating with the HA hydrogel to a final thickness of 54 ± 9 µm. Compression, bending, and tensile tests
indicated that these coatings did not significantly change
the mechanical properties of the braided conduits (data not
shown).

Assessment of regeneration of the rat sciatic
nerve
To evaluate the basic capacity to support nerve regeneration, E0000 braided conduits were tested in the
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well-described 1 cm gap rat sciatic nerve injury model.36,37
Treatment groups included the uncoated braided conduit
(n = 7) (Group 1), braided conduits coated with HA (n = 7)
(Group 2), braided conduits coated with the electrospun
E1001(1k) polymer fiber mats (n = 4) (Group 3), and
braided conduits coated sequentially with the electrospun
E1001(1k) polymer followed by HA (n = 4) (Group 4). A
control group of an autograft (n = 7) inverted within the
injury site was used (Group 5) and the regenerated nerves
of all five groups were collected after 16 weeks.

Histomorphometric analysis of explanted nerve
Sections of the regenerated nerve segments from the
center of conduits showed that all test conduits supported
regeneration of axons, but significant variation was
observed (Figure 5). Uncoated conduits (Group 1), conduits having an electrospun fiber coating (Group 3), and
conduits having an electrospun fiber coating plus an HA
coating (Group 4) all exhibited evidence of fibrous tissue
infiltration that disrupted the formation of densely packed
nerve bundles and prevented the formation of a welldefined epineurium. Only the HA-coated conduits (Group
2) supported the formation of rounded and densely packed
nerve cables with tightly packed fascicles and axons.
Regenerated nerves within the HA-coated conduits
(Group 2) all appeared to have formed an epineurial layer
and resembled most closely the histomorphological
appearance of the nerve bundles formed in autologous
grafts (Group 5). Regenerated nerves within autologous
grafts were, as expected, highly organized with a mature
epineurium.
Based on these histomorphological findings, we concluded that among all barrier coatings, only the cell-repellent cross-linked HA coating (Group 2) was able to reduce
the infiltration of fibrous tissue sufficiently to allow for the
regeneration of healthy looking nerve tissue. It was a surprising finding that the tightly packed electrospun mats
used in Group 3, and even the combination of electrospun
mats and HA coating (Group 4) did not prevent significant
cell infiltration into the conduit (see Figure 5 for details).
Histomorphometric characterization showed that the
area occupied by myelinated axons was largest in uncoated
braided conduits (Group 1), which was comparable to
autologous grafts (Figure 6). HA-coated conduits (Group
2) showed the next largest myelinated area, followed by
conduits of Group 4 and lastly by conduits of Group 3. In
contrast, the axonal density was the highest in Group 2
conduits and lowest in Group 1 conduits, confirming that
HA-coated conduits contained densely regenerated nerve
cables while uncoated braided conduits have large but
loosely packed nerve cables (Figure 6(b)). Assessment of
axonal myelination by measuring the G-ratio showed the
smallest G-ratio was obtained by autologous conduits
(Group 5), with all other groups having significantly larger

G-ratios. These results show that different outcome measures provide different trends and illustrate the need to
explore multiple outcome factors when assessing the histological features of regenerated nerve cables.
In comparison to the autologous grafts (Group 5),
HA-coated conduits (Group 2) had a greater number of
axons packed per unit area although these axons were less
mature (larger G-ratio, thinner myelin sheaths). One may
speculate that over longer time periods, the axons in the
HA-coated conduit group will likely mature further. Based
on the histomorphological evaluation of the regenerated
nerve cables, the conduits of Group 2 (HA-coated conduits) seem to provide the least amount of fibrous tissue
infiltration and the best milieu for nerve regeneration.

Muscle weight
In contrast to the histomorphological analysis of regenerated nerve cables, muscle weight is a functional outcome
measure that is directly related to the ability of a conduit to
restore mobility to an injured animal. Following sciatic
nerve bisection, the TA and gastrocnemius muscles innervated by branches of this nerve atrophy. Regaining of muscle weight on the operated side after nerve conduit
implantation is indicative of recovery. These muscles were
harvested from both hind limbs, and wet weights at the end
of the 16-week recovery period were plotted (Figure 7).
Muscle weight recovery of the injured side as compared to
the healthy side was the greatest with autologous graft
(Group 5), followed by the HA-coated braided conduits
(Group 2). Group 2 conduits lead to significantly higher
TA muscle weight recovery than any of the other test
groups. Improved TA muscle weight recovery with the
HA-coated braided conduits correlates with the higher
regenerated axon density in this group compared to
uncoated conduits and is, in our opinion, due to limiting
the degree of fibrous tissue infiltration and subsequent formation of an epineurial layer in these conduits.

Electrophysiology
Electrophysiological measurement of nerve conduction
through the defect is another measure of functional nerve
regeneration. We recorded the CMAP supramaximal
amplitude and latency of the peroneal and tibial nerves
(Figure 8). For both tibial and peroneal CMAP, the earliest
post-operative CMAP signals were detected by 8 weeks for
the autografts and 12 weeks for the conduit groups. 37% of
the CMAP signal was recovered in the autograft group
at the 16-week endpoint, which displayed the largest
amplitude among all treatment groups (Figure 8(a) and
(c)). Among the conduit groups, HA-coated braided conduits (Group 2) had the highest CMAP amplitudes with
approximately 14% of the CMAP signal recovered at the
16-week endpoint.
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Figure 5. Toluidine blue stained 1 µm thick cross-sections of conduits explanted after 16 weeks in-vivo. 5× images (left column)
show the whole conduit and nerve cable (dark stain), with varying numbers of myelinated axons and axon bundles as well as
blood vessels and fibrotic tissue in braided conduits, 40× images (middle column) show the interface between axonal tissue and
surrounding luminal area, and 100× images (right column) show representative high magnification images used in histomorphometric
measurements. (a) Uncoated braid (Group 1), (b) HA-coated braid (Group 2), (c) electrospun (ES) mat-coated braid (Group 3), (d)
ES and HA-coated braid (Group 4), and (e) autologous graft (Group 5). Regenerated tissue within Group 1 conduits showed many
regenerated axons within loosely organized fascicles. A considerable amount of non-nerve tissue with a fibrous appearance was
present. Similar features were noted for nerves that regenerated within braided conduits of Groups 3 and 4. The nerve cables in
Groups 3 and 4 conduits were smaller in size and variable in the presence of a boundary between axonal area and the surrounding
tissue. This result was surprising and suggests that the electrospun mat surrounding the braided conduit may have facilitated
fibrous tissue infiltration. In contrast, the HA-coated conduits (Group 2) all showed rounded and densely packed nerve cables
with tightly packed fascicles and axons and a well-formed epineurium. Regenerated nerves in Group 2 conduits were similar in
histomorphological appearance to regenerated nerves within autologous grafts.

Improvement in functional regeneration is evident by
the inverse correlation between CMAP latency and amplitudes. Accordingly, the autograft group had the lowest
peroneal and tibial latency values at 16 weeks indicating a
more rapid signal conduction (Figure 8(b) and (d)).

Observed latency values were equivalent for the braided
conduit groups with the exception of the ES-coated conduits (Group 3), which displayed longer latencies, in
agreement with fewer axons and greater G-ratio observed
in the histology of this group.
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Figure 6. Nerve histomorphometry: (a) the total surface area of the myelinated axonal tissue, (b) the density of the myelinated
nerve fibers, and (c) G-ratio; the ratio of inner axonal diameter to the total outer diameter. Data are represented as mean ± SE.

Figure 7. The ratio of the injured muscle weight (operated side) to the healthy muscle weight (contralateral side) of the (a) tibialis
anterior and (b) gastrocnemius muscles 16 weeks post-op. Data are represented as mean ± SE.
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Figure 8. Electrophysiological measurements of pre- and post-operative amplitude (top row) and latency (bottom row) for the
(a, b) tibial nerve and (c, d) peroneal nerve. Data are represented as mean ± SE.

Conclusion
Functional outcome measures in our study (electrophysiology and muscle weight) appear to support the histomorphological findings, indicating a major role of porosity and
cell infiltration in hindering nerve recovery following
injury. Perhaps most surprising result was the failure of the
densely packed electrospun fiber coatings (with or without
HA) to prevent the infiltration of non-nervous tissue into
the lumen of the conduit. Our unpublished in-vitro experience with mats similar to those used here is that seeded
cells rarely penetrate further than 60–80 µm. However, this
study found that in-vivo conduits coated with electrospun
fiber mats became enriched with fibrous tissue. We believe
that the extensive cell friendly surface area offered by the
mats overwhelmed the cell-repellent properties of HA in
Group 4 conduits. In addition, the conduit material (E0000)
and the fiber mat material (E1001(1k)) favored protein
adsorption and cellular attachment.33,35
We further conclude that the enhancement of nerve
regeneration in HA-coated conduits (Group 2) compared
to uncoated conduits (Group 1) is primarily due to the HA
coating acting as a cell-repulsive barrier. However, HA is a
highly adaptable material and has been used as a “filler”
material for conduits with positive results,53,54 raising the
possibility that nerve regeneration was enhanced by the
activity of HA directly on the nerves and independently of

barrier functions. However, the poor regeneration supported by braided conduits coated with an electrospun
layer and HA suggests that having this HA hydrogel in the
vicinity of the nerve is insufficient to positively affect
regeneration, and the barrier function of HA may have been
overcome by the tissue infiltration into the electrospun
barrier upon degradation of the HA layer. Going forward,
we anticipate that changes to the HA-coatings will lead to
further enhancements of nerve regeneration using braided
conduits. Studies are ongoing to achieve this by increasing
the number of HA dipcoating steps, modifying hydrogel
composition and cross-link density, and improving the
sterilization method to maintain stability and integrity of
the HA-coated conduits.
While it is implicit that conduits for long nerve gaps
need to be supplemented with bioactive components (i.e.
cells, growth factors, peptides, axonal constructs), the
prerequisite for the development of these devices is the
development of a long, flexible, kink-resistant, permeable, and degradable synthetic outer conduit that will
provide sufficient mechanical support and perfusion
throughout the period of nerve regeneration. While
braided conduits are promising because of their kinkresistance, we have shown here that the high level of
porosity associated with the braiding process facilitates
the infiltration of scar tissue into the conduit that will
adversely affect nerve recovery. We have overcome this

Clements et al.
problem by developing a secondary barrier coating based
on a HA-derived hydrogel to control the porosity of the
braided conduits. Since HA-coated braided conduits significantly improved the level of functional nerve recovery
as judged by several functional outcome measures as
compared with uncoated conduits or conduits coated with
electrospun fiber mats, we conclude that braided conduits
in conjunction with HA-hydrogel-based barrier coatings
are a promising, new technology to help improve peripheral nerve regeneration.
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